Meta-Analysis Evaluating Risk of Hyperkalemia Stratified by Baseline MRA Usage in Patients with Heart Failure Receiving SGLT2 Inhibitors.

Ahmed, Aymen; Ahmed, Warda; Arshad, Muhammad Sameer; Suri, Azeema; Amin, Emaan; Shahid, Izza; Memon, Muhammad Mustafa

Ahmed, Aymen; Ahmed, Warda; Arshad, Muhammad Sameer; Suri, Azeema; Amin, Emaan; Shahid, Izza; Memon, Muhammad Mustafa.

Afiliación

Ahmed A; Department of Medicine, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, Pakistan.
Ahmed W; Medical College, The Aga Khan University, Karachi, 74800, Pakistan.
Arshad MS; Department of Medicine, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, Pakistan. muhammadsameerarshad@gmail.com.
Suri A; Department of Medicine, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, Pakistan.
Amin E; Department of Medicine, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, Pakistan.
Shahid I; Division of Preventive Cardiology, Houston Methodist Academic Institute, Houston, TX, USA.
Memon MM; Department of Medicine, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, Pakistan.

Cardiovasc Drugs Ther ; 2023 Mar 15.

Article en En | MEDLINE | ID: mdl-36920647

Palabras clave

GDMT; Guideline directed medical therapy; Hyperkalemia; MRA; Mineralocorticoid receptor antagonist; Polypharmacy; SGLT2i

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Cardiovasc Drugs Ther Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google